Connect with us

Hi, what are you looking for?

Jewish Business News

World News

Perrigo again rejects improved Mylan offer

(L-R) Robert J Coury,   Mylan and Josegh Papa,   Periggo
Mylan offered Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share, for a total of $35.6 billion.

Perrigo Company (NYSE:PRGO; TASE:PRGO) board of directors has rejected Mylan’s improved offer.

Mylan N.V. had for the second time raised its offer to buy US-Irish-Israeli generic pharmaceuticals concern Perrigo company. Mylan is now offering Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share for a total of about $35.6 billion.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

The new offer reflects a share price of about $232.23 per Perrigo share based on prices on April 8 when Mylan made its first offer. The previous offer, which was rejected by Mylan, was for $222 per Perrigo share, comprising $60 in cash and 2.2 Mylan shares.


Published by Globes [online], Israel business news –



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.